Human Vaccines & Immunotherapeutics

Papers
(The H4-Index of Human Vaccines & Immunotherapeutics is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Safety of Sars-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance338
Prevalence and factors associated with hepatitis B virus infection among household members: a cross-sectional study in Beijing270
Individual and neighborhood factors associated with being unvaccinated against COVID-19 among pregnant persons228
Potential public health impact of the adjuvanted recombinant zoster vaccine among people aged 50 years and older in Beijing175
Attitudes of school teachers toward influenza and COVID-19 vaccine in Greece during the COVID-19 pandemic144
Beliefs and barriers of COVID-19 vaccination hesitancy among Sudanese healthcare workers in Sudan: A cross sectional study129
Reasons underlying the intention to vaccinate children aged 5-11 against COVID-19: A cross-sectional study of parents in Israel, November 2021120
COVID-19 vaccines associated with vasovagal malaise: A retrospective study in two mass vaccination centers and analysis of the WHO pharmacovigilance database118
The effectiveness of influenza vaccine among elderly Chinese: A regression discontinuity design based on Yinzhou regional health information platform107
Determinants of basic childhood vaccination coverage in European and OECD countries94
Human vaccines & immunotherapeutics: News October 202289
Clinical characteristics in immune thrombocytopenia patients after COVID-19 vaccination88
Geographical and time trends of measles incidence and measles vaccination coverage and their correlation in Nigeria71
The global mRNA vaccine patent landscape70
Effects of a web-based HPV vaccination intervention on cognitive outcomes among young gay, bisexual, and other men who have sex with men69
Nanovaccines: Merits, and diverse roles in boosting antitumor immune responses62
Challenges to COVID-19 vaccine introduction in the Democratic Republic of the Congo – a commentary60
Healthcare workers’ attitudes on mandates, incentives, and strategies to improve COVID-19 vaccine uptake: A mixed methods study60
Expanding access to COVID-19 testing, vaccination and treatment at a free clinic for uninsured Spanish-speaking adults in Providence, RI60
Vaccination with a shared oncogenic tumor-self antigen elicits a population of CD8+ T cells with a regulatory phenotype59
A qualitative investigation of facilitators and barriers to accessing COVID-19 vaccines among Racialized and Indigenous Peoples in Canada59
Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies57
Human vaccines & immunotherapeutics: News August 202257
The health and economic impact of switching vaccines in universal varicella vaccination programs using a dynamic transmission model: An Israel case study57
Human Vaccines & immunotherapeutics: News, June 202256
Correlation between anti-S IgG and neutralizing antibody titers against three live SARS-CoV-2 variants in BNT162b2 vaccine recipients54
Hepatitis A and B vaccination in adults at risk: A survey of US healthcare providers’ attitudes and practices53
Waning of maternal antibody against measles virus in Shufu, China52
Why the American Academy of Pediatrics recommends initiating HPV vaccine at age 952
Waning rate of immunity and duration of protective immunity against diphtheria toxoid as a function of age and number of doses: Systematic review and quantitative data analysis52
A systematic literature review of the epidemiology and burden of herpes zoster in selected locales in Asia Pacific52
A case of congenital rubella syndrome and epidemiology of related cases in China, 2014–202350
Hypophysitis after COVID-19 vaccination in a patient with Rathke’s cleft cyst: A case report49
How did the introduction of the measles-containing vaccine second dose (MCV2) affect measles vaccine uptake? – evidence from Nigeria47
Understanding barriers to influenza vaccination among parents is important to improve vaccine uptake among children47
Immunogenicity and safety of a COVID-19 DNA vaccine in healthy adults and elderly: A randomized, observer-blind, placebo-controlled phase 2 trial45
Assessment of COVID-19 vaccine take-up and its predictors among healthcare professionals in public hospitals, Addis Ababa, Ethiopia: Facility-based cross-sectional study44
Determinants of healthcare workers perceptions, acceptance and choice of COVID-19 vaccines: a cross-sectional study from the United Arab Emirates40
Attitudes toward influenza vaccination in healthcare workers in Italy: A systematic review and meta-analysis40
Influenza vaccine coverage in 6months-64 years-old patients affected by chronic diseases: A retrospective cohort study in Italy39
60 Years of viral vaccines39
0.22636699676514